Owlet (OWLT) AI Stock Analysis

• Market Cap: $153.68M
• Dividend Yield: N/A
• Average Volume (3M): 91.49K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.39
• Revenue Growth: 36.87%
• EPS Growth: -78.47%
• Country: US
• Employees: 80
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Devices
• EPS (TTM): -0.05
• Shares Outstanding: 16,524,690
• 10 Day Avg. Volume: 79,471
• 30 Day Avg. Volume: 91,487
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.97
• Enterprise Value/Revenue: 1.77
• Enterprise Value/Gross Profit: 3.40
• Enterprise Value/Ebitda: -14.40
• 1Y Price Target: $13.20
• Price Target Upside: 41.94% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5

• Rating: 62 Neutral
• Price Target: $10.00 ▲(7.53% Upside)

Owlet's stock score is driven by strong technical indicators and positive earnings call sentiment, highlighting robust revenue growth and strategic partnerships. However, significant financial challenges, including negative equity and cash flow issues, weigh down the score. Recent corporate events provide a strategic boost, but the negative P/E ratio and lack of dividend yield limit valuation appeal.

Positive Factors

Market Position

Owlet dominates the smart baby monitor segment, being the first and only FDA-cleared smart baby monitors presently on the market.

Partnerships

OWLT announced a new partnership with the Children's Hospital of The King's Daughter, allowing babies to leave the hospital with an OWLT monitor.

Revenue

International revenue growth was strong, marking a 104% year-over-year increase.

Negative Factors

Gross Margin

Management lowered the gross margin guide due to tariff concerns.

Owlet Business Overview & Revenue Model

Company Description

Owlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Smart Sock, a baby monitor to track an infant's oxygen levels, heart rates, and sleep trends; Dream Sock, an app to assist children for better sleep; Cam, a video streaming app to hear and see baby from anywhere; and Dream Lab, an interactive online platform that assists families in building healthy sleep habits. The company also offers Dream Duo, a monitoring system for baby's sleeping habits and includes wearable sock monitor, HD video, and digital sleep coach. Owlet, Inc. was founded in 2012 and is based in Lehi, Utah.

How the Company Makes Money

Owlet makes money primarily through the sale of its Smart Sock and other related products, such as the Owlet Cam, which provides HD video streaming and audio monitoring for parents. The company generates revenue by selling these products directly through its website and through various retail partners. Owlet also offers subscription services that provide users with enhanced features, such as historical data tracking and personalized insights. Significant partnerships with distributors and retailers help expand its market reach, contributing to its revenue streams. Additionally, Owlet invests in research and development to continually innovate and introduce new products, which supports ongoing sales growth.

Owlet Financial Statement Overview

Summary

Owlet faces significant financial challenges, including persistent net losses, negative equity, and cash flow issues. While there is recent revenue growth and improvements in EBITDA, the company's high liabilities and negative cash flows remain concerning.

Income Statement

Owlet's revenue shows inconsistency, with recent growth from 2023 to TTM after a dip. However, persistent negative net income and negative EBIT margins indicate ongoing profitability issues. The company has shown some improvement in EBITDA, suggesting potential for operational efficiency gains.

Balance Sheet

The balance sheet reveals significant challenges, with negative stockholders' equity indicating potential solvency issues. The debt-to-equity ratio calculation is not feasible due to negative equity, but the high total liabilities relative to assets suggest financial instability.

Cash Flow

Free cash flow remains negative, indicating ongoing liquidity challenges. The operating cash flow to net income ratio is negative, highlighting inefficiencies in translating revenue into cash. Despite these challenges, there is a positive trend in financing cash flow, reflecting efforts to bolster liquidity through external funding.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	78.06M	54.01M	69.20M	75.80M	75.40M
Gross Profit	39.31M	22.59M	23.30M	35.00M	35.88M
EBITDA	-9.47M	-27.49M	-75.53M	-42.71M	-8.25M
Net Income	-12.54M	-32.90M	-79.29M	-98.17M	-10.52M
Balance Sheet
Total Assets	49.52M	44.12M	58.10M	140.00M	40.12M
Cash, Cash Equivalents and Short-Term Investments	20.25M	16.56M	11.20M	95.10M	17.01M
Total Debt	11.70M	15.22M	16.30M	16.50M	28.84M
Total Liabilities	66.33M	73.80M	68.70M	84.80M	60.94M
Stockholders Equity	-16.81M	-29.68M	-10.60M	55.20M	-20.82M
Cash Flow
Free Cash Flow	-11.97M	-23.59M	-82.97M	-42.62M	-1.19M
Operating Cash Flow	-11.21M	-23.53M	-81.40M	-40.60M	-129.00K
Investing Cash Flow	-761.00K	-59.00K	-1.60M	-2.00M	-1.06M
Financing Cash Flow	16.04M	28.91M	-900.00K	120.60M	6.46M

Owlet Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 9.30
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OWLT, the sentiment is Positive. The current price of 9.3 is above the 20-day moving average (MA) of 7.99, above the 50-day MA of 7.51, and above the 200-day MA of 5.27, indicating a bullish trend. The MACD of 0.06 indicates Positive momentum. The RSI at 63.98 is Neutral, neither overbought nor oversold. The STOCH value of 52.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OWLT.

Owlet Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	64 Neutral	CHF27.11B	16.51	9.31%	2.32%	30.32%	7.54%
OWLT	62 Neutral	$153.68M	―	60.56%	―	36.87%	-78.47%
ICAD	60 Neutral	$106.31M	―	-16.53%	―	-4.15%	3.49%
XTNT	54 Neutral	$86.38M	―	-26.20%	―	20.81%	-498.66%
HYPR	54 Neutral	$90.29M	―	-67.86%	―	0.34%	6.20%
BFLY	44 Neutral	$334.82M	―	-29.42%	―	23.13%	46.62%
CTSO	43 Neutral	$62.76M	―	-68.84%	―	-5.86%	50.76%

Owlet Corporate Events

Owlet Enters Exchange Agreement with Warrant Holders

On August 7, 2025, Owlet, Inc. entered into an Exchange Agreement with certain holders of its Series A and Series B Warrants to exchange these warrants for newly issued shares of Common Stock. This agreement, which involves exchanging warrants for over 9 million shares for approximately 5.4 million new shares, is subject to stockholder approval and customary closing conditions. The transaction aims to streamline the company’s capital structure and involves significant stakeholders, including Eclipse Ventures LLC and Trilogy Equity Partners, who have agreed to support the proposal at the 2025 Annual Meeting. The agreement includes a lock-up period for the exchanged shares and provisions for registration rights, indicating a strategic move to enhance shareholder value and align interests among key investors.

The most recent analyst rating on (OWLT) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.

Owlet Announces CEO Transition Effective October 2025

Owlet, Inc. announced the resignation of CEO Kurt Workman, effective October 1, 2025, who will transition to Executive Chairman, with Jonathan Harris succeeding him as CEO. The company reported strong financial results for Q2 2025, with a 25.9% increase in revenue year-over-year and improvements in gross margin and adjusted EBITDA, positioning Owlet for continued growth in the pediatric health market.

The most recent analyst rating on (OWLT) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.

Owlet Amends Credit Agreement to Boost Flexibility

On June 11, 2025, Owlet, Inc. and its subsidiary Owlet Baby Care, Inc. entered into a First Amendment to their Credit and Security Agreement with financial institutions and ABL OPCO LLC. This amendment modifies financial covenants, increases allowable capital expenditures, and expands borrowing eligibility against certain accounts receivable, potentially enhancing the company’s financial flexibility and operational capacity.

The most recent analyst rating on (OWLT) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.